- Home
- ARMP vs NAGE Comparison
ARMP vs NAGE Comparison
Compare ARMP & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.7M | 239.0M |
| IPO Year | 1996 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ARMP | NAGE |
|---|---|---|
| Price | $5.41 | $3.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $15.00 | ★ $16.00 |
| AVG Volume (30 Days) | 93.2K | ★ 406.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $34.44 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $2.86 | $2.87 |
| 52 Week High | $14.98 | $10.52 |
Technical Indicators
Market Signals| Indicator | ARMP | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 55.53 | 42.60 |
| Support Level | $5.12 | $2.91 |
| Resistance Level | $5.63 | $3.61 |
| Average True Range (ATR) | 0.47 | 0.10 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 84.37 | 9.84 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.